Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Childs

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
JCO Oncology Practice|October 31, 2022
Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic ChemotherapyDaniel S Childs, David A Helfinstine, Lindsey Sangaralingham, et al.
Journal of Pain and Symptom Management|May 2, 2021
Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide SurveyWil L Santivasi, Daniel S Childs, Kelly L Wu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2023
An evaluation of the effect of lithium on taxane-induced neuropathyDavid C Kochan, Paul J Novotny, Elizabeth J Cathcart-Rake, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2024
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysisOsama Mosalem, Winston Tan, Alan H Bryce, et al.
Haematologica|April 3, 2025
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapyYael Kusne, Osama M Mosalem, Jaxon Quillen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2026
Safely Stopping Premedications in Patients Receiving Paclitaxel: A Randomized TrialMichael Berger, Maryam Lustberg, Paul J Novotny, et al.
Clinical Genitourinary Cancer|June 22, 2026
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA ProfilingNancy Wei, Jamie J O'Byrne, Miguel Muniz, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
BJUI Compass|February 19, 2024
Low PSA radiographic disease progression on C11-choline PETAhmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research RetreatAkeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
JCO Oncology Practice|October 31, 2022
Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic ChemotherapyDaniel S Childs, David A Helfinstine, Lindsey Sangaralingham, et al.
Journal of Pain and Symptom Management|May 2, 2021
Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide SurveyWil L Santivasi, Daniel S Childs, Kelly L Wu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2023
An evaluation of the effect of lithium on taxane-induced neuropathyDavid C Kochan, Paul J Novotny, Elizabeth J Cathcart-Rake, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2024
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysisOsama Mosalem, Winston Tan, Alan H Bryce, et al.
Haematologica|April 3, 2025
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapyYael Kusne, Osama M Mosalem, Jaxon Quillen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2026
Safely Stopping Premedications in Patients Receiving Paclitaxel: A Randomized TrialMichael Berger, Maryam Lustberg, Paul J Novotny, et al.
Clinical Genitourinary Cancer|June 22, 2026
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA ProfilingNancy Wei, Jamie J O'Byrne, Miguel Muniz, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
BJUI Compass|February 19, 2024
Low PSA radiographic disease progression on C11-choline PETAhmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research RetreatAkeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Pageof 6